Get started
RocketTickers

SCYNEXIS Announces Positive Results from Its Pivotal Phase 3 CAN

Long
SCYNEXIS, Inc. (NASDAQ:SCYX)  
RocketTickers  
NASDAQ:SCYX   SCYNEXIS, Inc.
Beyond Technical Analysis
0
1
beyondta
SCYX: Scynexis
2022-02-10 07:36:33
SCYNEXIS Announces Positive Results from Its Pivotal Phase 3 CANDLE Study of Oral Ibrexafungerp for Prevention of Recurrent Vaginal Yeast Infections, Clearing the Way for Regulatory Submission and Potential Approval of Additional Indication by End of 2022
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.